How to get retail out of PPHM
RRdog mentioned that we kinda get the bears' message, after hearing it thousands of times.
But a good point the bears do make is what-in-the-world are they going to do with all the retail Joe Six-Packs in the stock. Is GILD or PFE or Roche really going to mint all those slobs (meaning us) as multi-millionaires?
I think not. So the plan will utilize the pressure-valve approach. We've got a lot of bitter investors here, and that's FULLY understandable, given what's gone down since bloodbath Monday, September 24, 2012. It's been a hard road.
But how many us predicted where PPHM is now? Answer: no one. Nobody called MSK, nobody called AZN collaboration, nobody called NCCN, nobody called non-UTSW researchers talkin up PS blockade.
So the ONE THING certain for our future is that NO ONE will call it here. Everything so far has come out of the blue. For those of here for YEARS, we talked so much more about NSCLC because we thought that Bavi was just a lung cancer drug. We were talking with each other and did not know Bavi's MOA nor did PPHM.
So when the big bolt comes from the sky, we'll be caught off-guard, that much is sure. Because we really haven't called anything correctly, so far, (with the exception of threshing out the MDSC-crushing, immune-stoking, adaptive-immunity talents of our little molecule, Bavi.
Caught off-guard, we'll leap for joy and SELL. Just like good little retailers. Give 'em $5 pps, or $10 pps, or $20 pps, and just watch the little rats bail. All those lovely freed-up shares, to be quickly snapped up by 'tutes and the big boys.
With a cornerstone molecule, $20 pps is truly breadcrumbs. $200 pps is getting there, for a start. But the pressure valve will clean out retail and much lower sell points.
It's just a matter of time.
Regards,
Joe (Six-Pack) (**grin)
